The workflow links several analytical stages inside a disposable cartridge. The system processes the specimen, purifies nucleic acids, amplifies selected targets through real-time polymerase chain reaction, and follows fluorescence during amplification. The resulting signal pattern supports qualitative detection or quantitative measurement, allowing the instrument to report molecular findings without requiring separate preparation, amplification, and detection workflows.
Real-time PCR provides the amplification step needed to detect clinically relevant genetic material. As target nucleic acids are amplified, fluorescent signals are monitored rather than evaluated only after the reaction is complete. This integrated measurement enables the system to distinguish whether a target is detected and, when the assay supports it, provide a quantitative result.
The cartridge contains specimen processing, nucleic-acid purification, amplification, and signal detection within a standardized workflow. Enclosure limits the need to transfer material between separate stages, while standardization reduces variation caused by hands-on manipulation. Together, these features promote reproducible testing and help limit contamination risk, which is especially relevant when handling infectious specimens or amplified nucleic acids.
A specimen is processed through a disposable cartridge, where target nucleic acids are purified and then amplified by real-time PCR. The instrument monitors fluorescence during amplification and converts the measured signal into a qualitative or quantitative result. Because these stages are integrated, the operator has limited hands-on manipulation compared with workflows requiring separate preparation, amplification, and detection steps.
The platform is useful when investigators or clinicians need molecular evidence of an infectious agent or a clinically relevant antimicrobial-resistance marker. Its integrated workflow supports rapid testing while reducing manual processing. Results can then be considered alongside disease status and treatment decisions, making the system relevant to both infection diagnostics and research that connects pathogen detection with clinical interpretation.
In this subject area, molecular findings can be connected with the broader status of an infectious disease rather than viewed as isolated laboratory signals. Detection of a pathogen or resistance-associated genetic target may help investigators examine disease-related patterns and treatment relevance. The platform contributes standardized, reproducible measurements that support this connection while limiting contamination-prone handling steps.